Secondaries announced 11.5.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Marinus Pharmaceuticals Symbol: MRNS Price: Last trade $7.73 Trade Date: 11/6 Shares: 3.9 million Underwriter(s) Jefferies, RBC Capital Markets Rating=Subscription Needed[…]
